---
figid: PMC6316656__cells-07-00272-g002
figlink: /pmc/articles/PMC6316656/figure/cells-07-00272-f002/
number: F2
caption: Mechanisms of Hedgehog pathway activation in cancer. Ligand-independent activation
  is due to inactivating mutations in the negative regulators PTCH1 or SUFU, activating
  mutations in SMO, or amplification of GLI activators. Ligand-dependent activation
  occurs through autocrine, paracrine, or inverse paracrine mechanisms (see text for
  details). In the autocrine mechanism, tumor cells secrete and respond to HH ligands;
  in the paracrine pattern tumor cells produce HH ligands, which activate HH pathway
  in stroma cells; in the reverse-paracrine mechanism stroma cells produce HH ligands,
  which activate HH pathway in tumor cells. PTCH1, Patched 1; SMO, Smoothened; SUFU,
  Suppressor of Fused; HH, hedgehog ligand; GLIA, GLI activators; IL6, Interleukin-6;
  IGF, Insulin Growth Factor; VEGF, Vascular Endothelial Growth Factor; Wnt, Wingless/Integrated.
pmcid: PMC6316656
papertitle: 'Targeting the Oncoprotein Smoothened by Small Molecules: Focus on Novel
  Acylguanidine Derivatives as Potent Smoothened Inhibitors.'
reftext: Silvia Pietrobono, et al. Cells. 2018 Dec;7(12):272.
pmc_ranked_result_index: '88832'
pathway_score: 0.8126464
filename: cells-07-00272-g002.jpg
figtitle: Hedgehog pathway activation in cancer
year: '2018'
organisms: Homo sapiens
ndex: df80c747-df14-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6316656__cells-07-00272-g002.html
  '@type': Dataset
  description: Mechanisms of Hedgehog pathway activation in cancer. Ligand-independent
    activation is due to inactivating mutations in the negative regulators PTCH1 or
    SUFU, activating mutations in SMO, or amplification of GLI activators. Ligand-dependent
    activation occurs through autocrine, paracrine, or inverse paracrine mechanisms
    (see text for details). In the autocrine mechanism, tumor cells secrete and respond
    to HH ligands; in the paracrine pattern tumor cells produce HH ligands, which
    activate HH pathway in stroma cells; in the reverse-paracrine mechanism stroma
    cells produce HH ligands, which activate HH pathway in tumor cells. PTCH1, Patched
    1; SMO, Smoothened; SUFU, Suppressor of Fused; HH, hedgehog ligand; GLIA, GLI
    activators; IL6, Interleukin-6; IGF, Insulin Growth Factor; VEGF, Vascular Endothelial
    Growth Factor; Wnt, Wingless/Integrated.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - SUFU
  - PTCH1
  - WNT9B
  - WNT10A
  - IL6
  - WNT5A
  - WNT6
  - WNT7A
  - SMO
  - WNT9A
  - WNT4
  - WNT1
  - GLI1
  - WNT3
  - WNT5B
  - WNT3A
  - WNT2
  - VEGFD
  - PGF
  - VEGFA
  - WNT8B
  - WNT2B
  - VEGFC
  - WNT16
  - WNT10B
  - WNT7B
  - WNT8A
  - WNT11
  - VEGFB
  - Cancer
genes:
- word: SUFU
  symbol: SUFU
  source: hgnc_symbol
  hgnc_symbol: SUFU
  entrez: '51684'
- word: PTCH1
  symbol: PTCH1
  source: hgnc_symbol
  hgnc_symbol: PTCH1
  entrez: '5727'
- word: VEGF,Wnts
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT9B
  entrez: '7484'
- word: VEGF,Wnts
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT10A
  entrez: '80326'
- word: IL6,IGF,
  symbol: IL6
  source: hgnc_symbol
  hgnc_symbol: IL6
  entrez: '3569'
- word: VEGF,Wnts
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT5A
  entrez: '7474'
- word: VEGF,Wnts
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT6
  entrez: '7475'
- word: VEGF,Wnts
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT7A
  entrez: '7476'
- word: SMO
  symbol: SMO
  source: hgnc_symbol
  hgnc_symbol: SMO
  entrez: '6608'
- word: VEGF,Wnts
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT9A
  entrez: '7483'
- word: VEGF,Wnts
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT4
  entrez: '54361'
- word: VEGF,Wnts
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT1
  entrez: '7471'
- word: GLI
  symbol: GLI
  source: hgnc_prev_symbol
  hgnc_symbol: GLI1
  entrez: '2735'
- word: VEGF,Wnts
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT3
  entrez: '7473'
- word: VEGF,Wnts
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT5B
  entrez: '81029'
- word: VEGF,Wnts
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT3A
  entrez: '89780'
- word: VEGF,Wnts
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT2
  entrez: '7472'
- word: VEGF,Wnts
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
- word: VEGF,Wnts
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: PGF
  entrez: '5228'
- word: VEGF,Wnts
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: VEGF,Wnts
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT8B
  entrez: '7479'
- word: VEGF,Wnts
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT2B
  entrez: '7482'
- word: VEGF,Wnts
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
- word: VEGF,Wnts
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT16
  entrez: '51384'
- word: VEGF,Wnts
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT10B
  entrez: '7480'
- word: VEGF,Wnts
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT7B
  entrez: '7477'
- word: VEGF,Wnts
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT8A
  entrez: '7478'
- word: VEGF,Wnts
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT11
  entrez: '7481'
- word: VEGF,Wnts
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFB
  entrez: '7423'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
figid_alias: PMC6316656__F2
redirect_from: /figures/PMC6316656__F2
figtype: Figure
---
